Acasti Pharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
25 Sep 23 | Buy€1,180,312 | Vimal Kavuru | Individual | 676,371 | €1.75 | |
25 Sep 23 | Buy€1,180,376 | Vimal Kavuru | Individual | 676,371 | €1.75 | |
31 Aug 23 | Buy€720 | Donald Olds | Individual | 381 | €1.89 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 124,344 | 1.32% |
VC/PE Firms | 497,359 | 5.29% |
Institutions | 772,685 | 8.22% |
Individual Insiders | 2,411,487 | 25.7% |
General Public | 5,593,529 | 59.5% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 26.4%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,188,076 | €3.6m | 0% | no data | |||
781,592 | €2.4m | 0% | no data | |||
497,359 | €1.5m | 0% | 0.67% | |||
494,698 | €1.5m | 0% | no data | |||
370,354 | €1.1m | 0% | no data | |||
217,381 | €656.9k | 530% | 0.21% | |||
124,344 | €375.8k | 0% | no data | |||
37,895 | €114.5k | 0% | no data | |||
36,650 | €110.8k | 0% | no data | |||
21,357 | €64.5k | 0% | no data | |||
12,000 | €36.3k | -61.3% | no data | |||
11,119 | €33.6k | 0% | no data | |||
3,112 | €9.4k | 1.04% | no data | |||
2,901 | €8.8k | 0% | no data | |||
1,947 | €5.9k | -65.2% | no data | |||
1,882 | €5.7k | 0% | no data | |||
1,500 | €4.5k | 11,400% | no data | |||
1,094 | €3.3k | 0% | no data | |||
584 | €1.8k | 0% | no data | |||
28 | €85.2 | 0% | no data | |||
2 | €5.7 | 0% | no data |